omni
aabb

sponsored

Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.

All over the world more than 22,500 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.